Rare bacteria in urine refers to uncommon microorganisms found during a urine culture that fall outside the usual suspects, particularly E. coli, which causes roughly 80% of urinary tract infections. These lesser-known species include bacteria like Aerococcus, Actinotignum, Corynebacterium, and members of the Serratia, Citrobacter, and Morganella families. They can genuinely cause infections, but many have been historically overlooked because standard lab methods weren’t designed to detect them.
If your urine culture returned an unfamiliar bacterial name, or if repeated cultures come back “negative” despite ongoing symptoms, understanding these organisms can help you make sense of what’s happening.
Why Standard Tests Miss These Bacteria
The standard urine culture, which has been the go-to diagnostic tool for decades, is optimized for fast-growing bacteria like E. coli. Labs typically incubate a small urine sample on one or two types of growth media for 24 hours. That works well for common pathogens, but many rarer species grow slowly, need specialized nutrients, or require specific atmospheric conditions like reduced oxygen. If a bacterium needs 48 to 72 hours to form visible colonies, a 24-hour culture will miss it entirely.
Basic screening tests can also fall short. Urine dipsticks detect nitrites, which are produced when certain bacteria convert nitrate in the urine. But several uncommon species lack this ability, so the dipstick reads negative even when infection is present. Actinotignum schaalii is a prime example: it doesn’t produce nitrite, grows only in carbon dioxide-enriched or low-oxygen environments, and won’t appear on the chromogenic media many labs use as their default.
Newer identification technology, particularly a method called MALDI-TOF mass spectrometry, has improved detection significantly. This technique identifies bacteria by their unique protein fingerprint. However, it still relies on a culture step first, and its reference library currently contains around 3,300 species. Searching broader genomic databases (which now catalog over 20,000 bacterial species) allows labs to identify virtually any organism, but this takes longer and isn’t part of routine practice everywhere.
Expanded Urine Culture (EQUC)
A more thorough approach called expanded quantitative urine culture uses a larger volume of urine, multiple types of growth media, varied atmospheric conditions, and longer incubation times (up to five days or more). First described in 2014, this method uncovers a wide range of bacteria and fungi that standard cultures miss. It’s not yet available at every lab, but it’s increasingly used in research and specialty settings when patients have persistent urinary symptoms with negative standard cultures.
Common Types of Rare Uropathogens
Aerococcus Urinae
Aerococcus urinae primarily affects older adults. In one study, the median age of patients with this infection was 79, compared to 69 for those with E. coli UTIs. Both men and women are equally affected. Chronic diseases and indwelling catheters are significant risk factors. Symptoms look like a typical UTI: painful urination, frequent urges, waking at night to urinate, blood in urine, groin pain, and fever. In elderly patients, it can also cause confusion or altered mental status, which may be the first noticeable sign.
One important clinical detail: Aerococcus urinae is often resistant to sulfonamides and fluoroquinolones, two antibiotic classes commonly prescribed as first-line UTI treatments. It tends to respond well to penicillin-type antibiotics and nitrofurantoin. If you’ve been treated for a UTI with a standard antibiotic and it didn’t resolve, this kind of mismatch between the bug and the drug could be the reason.
Actinotignum Schaalii
This slow-growing bacterium mainly affects elderly people and those with underlying urinary tract conditions like bladder or prostate cancer, urinary incontinence, catheter use, enlarged prostate, or neurogenic bladder. It’s found more frequently in men than women. In one large study, UTI caused by Actinotignum occurred in 0.18% of male urine samples versus 0.05% of female samples.
What makes this organism particularly tricky is that it’s resistant to many antibiotics used for empiric UTI treatment, and it’s genuinely difficult to grow in the lab. Patients with Actinotignum infections often have structural or functional abnormalities of the urinary tract at much higher rates (about 54%) compared to patients with UTIs from other organisms (37%). Because it requires special growth conditions, it’s one of the bacteria most likely to be present but undetected on a standard culture.
Corynebacterium Urealyticum
This species stands out because of what it does to your urine chemistry. Corynebacterium urealyticum produces an enzyme that breaks down urea into ammonia, making the urine highly alkaline. That shift in pH causes minerals to crystallize into struvite stones. In severe cases, these crystite crystals coat the bladder wall in a condition called encrusted cystitis, which involves hard mineral deposits forming directly on the bladder lining.
It’s a slow grower, tends to colonize skin and the urinary tract, and has a particular affinity for uroepithelial cells. It also readily forms biofilms on medical devices like catheters, making it harder to clear. Perhaps most concerning, it characteristically displays multidrug resistance, so standard antibiotics frequently fail against it.
Streptococcus Anginosus Group
Long considered harmless mouth and gut bacteria, the Streptococcus anginosus group is now increasingly recognized as opportunistic pathogens. These bacteria can cause urinary infections, particularly in people with weakened immune systems or structural urinary problems. Their reclassification from harmless commensals to potential pathogens is relatively recent, which means older lab protocols may still dismiss them as contaminants.
Other Uncommon Gram-Negative Species
Several members of the Enterobacteriaceae family, including Serratia, Citrobacter, Morganella, Providencia, and Pantoea, are detected quite rarely in urine but all have the capacity to cause true infections. Unlike the slow-growing organisms above, these are actually detectable by standard culture methods. They’re simply uncommon causes of UTI and tend to appear in hospitalized patients or those with complicated urinary histories.
Who Is Most at Risk
Rare uropathogens disproportionately affect certain groups. The strongest risk factors include advanced age, indwelling urinary catheters (both short and long-term), repeated catheterization, and structural abnormalities of the urinary tract. People with neurogenic bladder, where nerve damage impairs normal bladder function, face elevated risk partly because of the catheterization needed to manage the condition and partly because of increased residual urine volume that gives bacteria time to multiply.
Immunosuppression, diabetes, urinary incontinence, anterior vaginal wall prolapse, and poor hygiene also increase vulnerability. Many rare uropathogens thrive specifically in the setting of a compromised urinary tract, which is why they’re seen more often in patients with bladder or prostate cancer, urethral narrowing, or chronic kidney problems. If you have one or more of these risk factors and keep getting UTI symptoms that don’t respond to treatment, an uncommon organism is worth considering.
When Rare Bacteria Need Treatment
Finding bacteria in your urine doesn’t automatically mean you need antibiotics. Asymptomatic bacteriuria, where bacteria grow in the urine at significant levels but cause no symptoms, is common and usually doesn’t require treatment. Guidelines from the Infectious Diseases Society of America recommend against treating asymptomatic bacteriuria in most populations, including healthy premenopausal women, older adults, people with diabetes, those with spinal cord injuries, and patients with indwelling catheters. The two main exceptions are pregnant women and people about to undergo invasive urologic procedures.
This principle applies to rare bacteria as well. The key question is whether you have symptoms. For people with spinal cord injuries, recognizing symptoms can be complicated because the classic signs of a UTI (burning, urgency) may not be felt. Atypical presentations like increased spasticity, autonomic dysreflexia, or general malaise may be the only clues.
When rare bacteria are causing genuine symptoms, treatment requires knowing exactly which organism you’re dealing with and what it’s susceptible to. Many of these species are resistant to the antibiotics most commonly prescribed for UTIs. Aerococcus urinae resists fluoroquinolones. Actinotignum schaalii resists standard empiric treatments. Corynebacterium urealyticum is multidrug resistant. Starting with the wrong antibiotic won’t just fail to help; it gives the infection more time to establish itself. A targeted culture with sensitivity testing, even if it takes longer than usual, is essential for guiding effective treatment.
What to Do if You Suspect an Uncommon Infection
If you have persistent urinary symptoms but standard cultures keep coming back negative, the issue may be a slow-growing organism that your lab’s routine methods can’t detect. Ask whether your sample can be held longer in culture (48 to 72 hours instead of the standard 24), whether alternative growth media can be used, or whether your provider can order an expanded quantitative urine culture. Some reference laboratories and academic medical centers offer these specialized tests when local labs don’t.
Molecular testing, which detects bacterial DNA rather than relying on live growth, is another option that can identify organisms standard cultures miss. These tests can be particularly useful for patients with recurrent or treatment-resistant symptoms, structural urinary abnormalities, or a history of catheter use where uncommon organisms are more likely to be involved.